Literature DB >> 16122788

MDR1 P-gp expression and activity in intact human placental tissue; upregulation by retroviral transduction.

D E Atkinson1, C P Sibley, L J Fairbairn, S L Greenwood.   

Abstract

This study investigates P-gp activity in placental villous fragments and the possibility of upregulating its expression and function by retroviral transduction. In fresh fragments, cyclosporin A caused a significant increase in 3H-vinblastine accumulation (187+/-48% at 180 min n=4), consistent with multi-drug resistance activity. After 7 days in culture, villous fragments showed a similar increase in 3H-vinblastine accumulation (143+/-10% at 180 min n=4), which was not significantly different from that in fresh tissue. Following transduction, immunohistochemistry revealed increased P-gp expression. However, the distribution of the protein differed from that in controls, with P-gp being located throughout the tissue as opposed to the normal specific location on the maternal facing plasma membrane. Transduced explants showed a significantly larger increase in 3H-vinblastine accumulation in the presence of cyclosporin A than control explants (245+/-15.5% at 180 min, n=4), suggesting reduced capacity to efflux vinblastine. This study demonstrates P-gp activity in intact placental tissue which is maintained in explant culture. Retroviral transduction of P-gp to such tissue leads to increased but undirected expression of the protein. The consequent increased activity at sites such as the basal, fetal facing, plasma membrane probably explains the increased substrate accumulation within the tissue.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122788     DOI: 10.1016/j.placenta.2005.06.008

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  6 in total

Review 1.  An update on expression and function of P-gp/ABCB1 and BCRP/ABCG2 in the placenta and fetus.

Authors:  Lyrialle W Han; Chunying Gao; Qingcheng Mao
Journal:  Expert Opin Drug Metab Toxicol       Date:  2018-08-03       Impact factor: 4.481

2.  Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.

Authors:  Kristin M Bircsak; Vivek Gupta; Poi Yu Sofia Yuen; Ludwik Gorczyca; Barry I Weinberger; Anna M Vetrano; Lauren M Aleksunes
Journal:  J Pharmacol Exp Ther       Date:  2016-02-05       Impact factor: 4.030

Review 3.  Multidrug resistance: Physiological principles and nanomedical solutions.

Authors:  Sijumon Kunjachan; Błażej Rychlik; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2013-10-10       Impact factor: 15.470

4.  Gestational Age-Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics.

Authors:  Olena Anoshchenko; Bhagwat Prasad; Naveen K Neradugomma; Joanne Wang; Qingcheng Mao; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2020-06-26       Impact factor: 3.922

Review 5.  Transporter Regulation in Critical Protective Barriers: Focus on Brain and Placenta.

Authors:  Valerio Taggi; Mario Riera Romo; Micheline Piquette-Miller; Henriette E Meyer Zu Schwabedissen; Sibylle Neuhoff
Journal:  Pharmaceutics       Date:  2022-06-29       Impact factor: 6.525

6.  In Silico Modeling for Ex Vivo Placental Transfer of Morphine.

Authors:  Harvey Ho; Shengjie Zhang; Ken Kurosawa; Koji Chiba
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.